IE 11 is not supported. For an optimal experience visit our site on another browser.

AstraZeneca, Johnson & Johnson resume coronavirus vaccine trials


Drug makers AstraZeneca and Johnson & Johnson have announced that phase three clinical trials are resuming for their COVID-19 vaccine candidates. Both were put on hold in recent weeks due to safety concerns.